Cargando…

Constitutional p53 mutation in a non-Li-Fraumeni cancer family.

Detalles Bibliográficos
Autores principales:	Prosser, J., Porter, D., Coles, C., Condie, A., Thompson, A. M., Chetty, U., Steel, C. M., Evans, H. J.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1992
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977555/ https://www.ncbi.nlm.nih.gov/pubmed/1562462

Ejemplares similares

Chromosome instability in fibroblasts derived from Li–Fraumeni syndrome families without TP53 mutations
por: Boyle, J M, et al.
Publicado: (2000)

Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53.
por: Birch, J. M., et al.
Publicado: (1994)

Mutations in p53 do not account for heritable breast cancer: a study in five affected families.
por: Prosser, J., et al.
Publicado: (1991)

Exclusion of constitutional p53 mutations as a cause of genetic susceptibility to colorectal cancer.
por: Bhagirath, T., et al.
Publicado: (1993)

Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes
por: Frebourg, Thierry, et al.
Publicado: (2020)

Radiation-induced G(1) arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations
por: Boyle, J M, et al.
Publicado: (1999)

A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrier.
por: Varley, J. M., et al.
Publicado: (1998)

Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts
por: Burt, E C, et al.
Publicado: (2000)

Li-Fraumeni Syndrome
por: Vogel, Wendy H.
Publicado: (2017)

Li-Fraumeni syndrome--a molecular and clinical review.
por: Varley, J. M., et al.
Publicado: (1997)

The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype
por: Ruijs, Marielle WG, et al.
Publicado: (2009)

Germline TP53 Mutation and Clinical Characteristics of Korean Patients With Li-Fraumeni Syndrome
por: Park, Kyoung-Jin, et al.
Publicado: (2016)

The function of a heterozygous p53 mutation in a Li-Fraumeni syndrome patient
por: Li, Yang, et al.
Publicado: (2020)

The first documentation of Li-Fraumeni syndrome in Korea.
por: Bang, Y. J., et al.
Publicado: (1995)

Chromosome instability is a predominant trait of fibroblasts from Li-Fraumeni families.
por: Boyle, J. M., et al.
Publicado: (1998)

A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li–Fraumeni-like families
por: Calvete, Oriol, et al.
Publicado: (2015)

A Novel Variant in the TP53 Gene Causing Li–Fraumeni Syndrome
por: Papadimitriou, Dimitrios T., et al.
Publicado: (2023)

Pediatric Case of Li–Fraumeni Syndrome in Honduras
por: Martínez-Beckerat, R., et al.
Publicado: (2021)

Hematologic malignancies and Li–Fraumeni syndrome
por: Swaminathan, Mahesh, et al.
Publicado: (2019)

Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours.
por: Sedlacek, Z., et al.
Publicado: (1998)

Identification of a novel germ-line mutation in the TP53 gene in a Mexican family with Li-Fraumeni syndrome
por: Taja-Chayeb, Lucia, et al.
Publicado: (2009)

Heterogeneity of Li-Fraumeni Syndrome links to unequal gain-of-function effects of p53 mutations
por: Xu, Jie, et al.
Publicado: (2014)

A novel germline mutation of TP53 with breast cancer diagnosed as Li–Fraumeni syndrome
por: Kai, Masaya, et al.
Publicado: (2022)

A novel TP53 tandem duplication in a child with Li–Fraumeni syndrome
por: Xu, Feng, et al.
Publicado: (2022)

Rare TP53 variant associated with Li-Fraumeni syndrome exhibits variable penetrance in a Saudi family
por: AlHarbi, Musa, et al.
Publicado: (2018)

A Case of Li-Fraumeni Associated Thymoma
por: Sivayoganathan, Thibacg, et al.
Publicado: (2022)

Genetic and functional analysis of a Li Fraumeni syndrome family in China
por: Hu, Huaying, et al.
Publicado: (2016)

Caspase Activation and Aberrant Cell Growth in a p53(+/+) Cell Line from a Li-Fraumeni Syndrome Family
por: Sherif, Zaki A.
Publicado: (2015)

The relationship between radiation-induced G(1)arrest and chromosome aberrations in Li-Fraumeni fibroblasts with or without germline TP53 mutations
por: Boyle, J M, et al.
Publicado: (2001)

Case Report: Identification of a Novel Pathogenic Germline TP53 Variant in a Family With Li–Fraumeni Syndrome
por: Paduano, Francesco, et al.
Publicado: (2021)

Inhibiting the Priming for Cancer in Li-Fraumeni Syndrome
por: Pantziarka, Pan, et al.
Publicado: (2022)

Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in the Li-Fraumeni Syndrome model, Trp53(+/-) mice
por: Blackburn, Anneke C, et al.
Publicado: (2014)

Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits
por: Lammens, C. R. M., et al.
Publicado: (2010)

A new therapeutic basis for treating Li-Fraumeni Syndrome breast tumors expressing mutated TP53
por: Glazer, Robert I.
Publicado: (2010)

Li-Fraumeni Syndrome: A Rare Genetic Disorder
por: Tazin, Faria, et al.
Publicado: (2022)

Simultaneous Occurrence of Germline Pathogenic Allele Variants of TMEM127 and TP53 in a Brazilian Family With Li-Fraumeni Syndrome
por: Lima, Jose Viana, et al.
Publicado: (2021)

Cancer spectrum in TP53-deficient golden Syrian hamsters: A new model for Li-Fraumeni syndrome
por: Miao, Jinxin, et al.
Publicado: (2021)

Li–Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment
por: Rocca, Valentina, et al.
Publicado: (2022)

NSCLC With Synchronous EGFR Mutations in Li Fraumeni Syndrome: A Case Report
por: Marks, Jennifer A., et al.
Publicado: (2023)

Identification and characterization of TP53 gene Allele Dropout in Li-Fraumeni syndrome and Oral cancer cohorts
por: Haque, Mohammed Moquitul, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j79e76ogsbcsgao1rlekqd6ofj